Tang Capital Management »

Abcellera Biologics shares owned by Tang Capital Management

Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by Tang Capital Management from 13F filings

Historical chart of Tang Capital Management investment in Abcellera Biologics

Tip: Access up to 7 years of quarterly data

All positions including Abcellera Biologics held by Tang Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abcellera Biologics by Tang Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $6.0M 2.3M 2.60
2024-06-30 $1.4M 462k 2.96

More positions owned by Tang Capital Management

Evolus (EOLS)
Tarsus Pharmaceuticals (TARS)
Aurinia Pharmaceuticals (AUPH)
Miragen Therapeutics (VRDN)
Mirum Pharmaceuticals (MIRM)
Kalvista Pharmaceuticals (KALV)
Anaptysbio Inc Common (ANAB)
Immunocore Hldgs Ads (IMCR)
Vaxcyte (PCVX)
Biontech Se Sponsored Ads (BNTX)
Biosante Pharmaceuticals (ANIP)
Ptc Therapeutics I (PTCT)
Relay Therapeutics (RLAY)
Iteos Therapeutics (ITOS)
Applied Therapeutics (APLT)

View all positions for Tang Capital Management

Top funds holding Abcellera Biologics

Baker Bros. Advisors
Baillie Gifford & Co
Ing Investment Management
OrbiMed Advisors
Arrowpoint Asset Management
BlackRock
BlackRock
Renaissance Technologies
Tang Capital Management
Federated Investors
Two Sigma Investments
Guardian Capital Advisors
Two Sigma Advisers
Citadel Advisors
Novo A/S

View all funds holding Abcellera Biologics